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ABSTRACT
Objective To investigate the relationship between 
guidelines and the medical practitioners’ perception of 
optimal care for patients attending with an apparently 
uncomplicated acute sore throat in five countries 
(Australia, Germany, Sweden, UK and USA).
Design International cross- sectional survey.
Setting Primary healthcare (PHC).
Participants Medical practitioners working in PHC.
Main outcome measures ORs for: (A) perception of 
throat swabs as important, (B) perception of blood tests 
(C reactive protein, B- ESR and B- leucocytes) as important 
and (C) antibiotic prescriptions if no pathogenic bacteria 
isolated on throat swab.
Results Guidelines differed significantly; those 
recommending throat swabs (Sweden and USA) were 
associated with practitioners perceiving them as 
important. The UK guideline was the only one actively 
discouraging the use of throat swabs. Hence, compared 
with the USA (reference), a throat swab showing no 
pathogenic bacteria increased the probability of antibiotic 
prescribing in the UK with OR 3.2 (95% CI 1.7 to 6.1) for 
adults, whereas it reduced the probability in Sweden for 
adults OR 0.35 (95% CI 0.13 to 0.96) and children 0.19 
(95% CI 0.069 to 0.50).
Conclusions The differences between practitioners’ 
perceptions of best management were associated with 
their guidelines. It remains unclear if guidelines influenced 
medical practitioners’ perception or if guidelines merely 
reflect the consensus of current practice. A larger effort 
should be made to reach an international consensus in 
high- income countries about the best management of 
patients attending for an uncomplicated acute sore throat.
BACKGROUND
An uncomplicated acute sore throat is a 
common reason for attending a primary 
healthcare setting (PHC). In most countries, 
40%–86% of these patients are prescribed 
antibiotics.1–6 Antibiotic treatment may 
reduce the risk of rheumatic fever in situ-
ations where this is common.7–9 It has a 
modest effect on pain and a small effect on 
preventing suppurative complications.10 
These possible advantages must be weighed 
against the possible negative effects of antibi-
otic prescribing, such as antimicrobial resis-
tance and side effects.
Factors influencing antibiotic prescribing
Some of the factors influencing antibiotic 
prescribing are: (A) the patient’s propensity 
to visit a General Practitioner (GP) when ill, 
(B) the degree of access to an appointment 
with a GP, (C) the decision threshold for the 
GP to prescribe antibiotics and (D) the actual 
health of the patient based on their symp-
toms and signs.
The patient’s propensity to visit a GP is 
partly a personality factor11 combined with 
influences from government information 
campaigns as well as all other more or less 
accurate information available from friends, 
Strengths and limitations of this study
 ► This is the first study from several countries linking 
medical practitioners’ perception of best manage-
ment with their guidelines.
 ► The overall response rate was high (74%) despite 
the well- known difficulties in getting a high response 
rate in surveys handed out to medical practitioners.
 ► The cross- sectional design and the fact that percep-
tions of optimal management were used rather than 
actual performance are potential limitations.
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relatives, the press, social media and various internet 
sources.
The number of medical practitioners is increasing 
both in absolute numbers and on a per capita basis in 
most high- income countries.12 However, this is a double- 
edged sword when it comes to antibiotic prescribing 
being both potentially good and potentially bad. There is 
a direct association between attendance rates and antibi-
otic prescribing.6 13 Therefore, lowering the threshold to 
see a GP is likely to increase antibiotic prescribing. The 
threshold to see a GP is also lowered by the expansion of 
telemedicine where the patient can chat with a GP using 
an app on their phone.14 15
The threshold for a GP to prescribe antibiotics is influ-
enced by many factors, including their interpretation of 
the medical literature, experiences with previous patients, 
fear of litigation (in some settings), different perceptions 
of the degree of benefit versus harm of antibiotics, a desire 
to satisfy patient expectations and personal preference.16–20 
GPs prescribing habits may not primarily be guided by 
evidence- based medicine but rather by a number of other 
factors including what results in a prompt and pragmatic 
benefit.21 Hence, guidelines may theoretically be good, but 
they have a tendency to work less well in clinical practice.22 
Varying personal preferences and the need for a prompt 
and pragmatic solution result in a large proportion of 
medical practitioners ignoring guidelines that describe the 
best management of patients with a sore throat and instead 
developing their own individual behaviours.16 18 22–25 This 
individual behaviour manifests in differing prescribing 
habits with a variation between GPs regarding antibiotics 
for sore throat with a factor between 3 and 6.16 18 This varia-
tion in individual practitioner behaviour seems to be more 
pronounced in countries with less emphasis on antibiotic 
stewardship, less surveillance of over- the- counter sale of 
antibiotics and with no access to point- of- care tests (POCTs) 
for group A Streptococci (GAS).26 The actual health of the 
patient seem to be of some importance,27 but these symp-
toms and signs are often misinterpreted by the physician 
leading to unnecessary antibiotic prescribing.28
A multitude of interventions have attempted to change 
GPs’ prescribing of antibiotics for acute respiratory tract 
infections, including the sore throat. Some of these 
studies show a modest short- term benefit,29 30 but it seems 
difficult to prove that any of the attempts so far has any 
long- term benefit.30
Guidelines
An important goal of guidelines for managing patients 
with an apparently uncomplicated acute sore throat 
is to influence the medical practitioners’ threshold to 
prescribe antibiotics, making prescriptions better targeted 
to those patients most likely to benefit from it. The throat 
is easily assessible for swabbing in a way that is not possible 
for other respiratory tract infections such as suspected 
sinusitis or pneumonia. Hence, the main divider between 
Table 1 Applicable guidelines in participating countries
Australia34* Germany35* Sweden36 UK37* USA38*
Throat swabs Not mentioned. Throat swab can 
be used in cases of 
uncertainty.
Recommended if 
≥3 Centor criteria 
and if antibiotics is 
considered.
Throat swabbing 
has no clear 
advantage.
Recommended if ≥3 
Centor criteria.
B- CRP Not mentioned. CRP above a cut- off 
between 25–35 mg/L 
may add limited 
information suggesting 
bacterial aetiology.
Adds no useful 
information.
Not mentioned. Not mentioned.
B- ESR Not mentioned. Adds no useful 
information.
Not mentioned. Not mentioned. Not mentioned.
B- leucocytes Not mentioned. Adds no useful 
information.
Adds no useful 
information.




GAS GAS GAS Not mentioned. GAS
Threshold to 
prescribe AB
It is reasonable to 
prescribe antibiotics if 
symptoms are severe 
(Centor scores are 
not mentioned but the 
described threshold 
corresponds well with 
≥3 Centor criteria).
Consider antibiotics 
if ≥3 Centor criteria 
especially if prior 
contact to other GAS 
pharyngitis patients.
Only consider 
antibiotics if ≥3 
Centor criteria and if 
a point- of- care test 
for GAS is positive.
Consider 
antibiotics if ≥3 
Centor criteria 
or ≥4 FeverPAIN 
scores.
Prescribe antibiotics if 
≥3 Centor criteria and 
if a point of care test 
for GAS is positive.
*Most countries have several, more or less partly conflicting, guidelines for managing patients with an acute sore throat. The ones 
referred to here are those most commonly used within primary healthcare in the area where the survey was done.
CRP, C reactive protein; ESR, erythrocyte sedimentation rate; GAS, group A Streptococci.
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different sore throat guidelines is whether to rely solely 
on clinical scoring of symptoms and signs or to also rely 
on additional information obtained from a throat swab 
processed using culture or a POCT to detect the presence 
of GAS.31 However, it seems the impact guidelines have 
on medical practitioners’ perception of the best manage-
ment strategy for these patients is limited.32 33
The primary aim of this study was to investigate differ-
ence between countries in the OR for (a) perception of 
throat swabs as important, (b) perception of blood tests 
(C reactive protein (CRP), B- ESR and B- leucocytes) as 
important and (C) antibiotic prescriptions if no patho-
genic bacteria isolated on throat swab in patients with 
an apparently uncomplicated acute sore throat. The 
secondary aim was to explore other differences between 
countries in medical practitioners’ perceptions. Find-




Medical practitioners working in a PHC setting were 
asked to participate by one of the authors. In most cases, 
this was done at meetings for continuing professional 
education except in Germany where most surveys were 
posted and later followed up by a telephone reminder. 
A few questionnaires were collected at personal visits to 
clinics during their lunch break.
Data collection
A one- page survey first asked about demographic infor-
mation such as age, gender, year of graduation and expe-
rience as medical practitioner. The following questions 
asked about the perceived importance of different factors 
to guide antibiotic prescribing for patients attending with 
an apparently uncomplicated acute sore throat. The first 
question stated that ‘My decision to start antibiotics would 
in most cases of patients with a sore throat be based on…
 ► History of comorbidities affecting immunity.
 ► History with indicative acute symptoms.
 ► Patient’s wish to get antibiotics.
 ► Physical findings at examination (except fever).
 ► Fever >38 degrees Celsius/>100.4 Fahrenheit.
 ► Blood tests with high leucocyte count, erythrocyte 
sedimentation rate (ESR), C- reactive protein (CRP).
 ► Findings of bacteria from throat swab’ (without spec-
ifying if the swab were to be analysed using culture or 
a POCT).
For each of these alternatives, the medical practitioner 
could answer in a 5- grade Likert scale with ‘strongly agree’, 
‘agree’, ‘neutral’, ‘disagree’ and ‘strongly disagree’.
The second question was a hypothetical case scenario 
describing ‘a 25- year- old man presenting with a 3 day 
history of a sore throat and no cough. Physical examination 
shows red tonsils with a tonsillar exudate, tender anterior 
lymph nodes and temperature of 38.3 deg Celsius/100.94 
Fahrenheit. Your colleague sent a throat swab yesterday 
and is now unable to review the results. I would prescribe 
antibiotics if the throat swab showed growth of…’. A sepa-
rate response was requested for growth of GAS, group C 
Streptococci, group G Streptococci, Fusobacterium necro-
phorum (FN), Haemophilus influenzae and finally if none 
of the previously mentioned bacteria were found. The 
medical practitioner could answer in a 4- grade Likert 
scale with ‘yes definitely’, ‘yes probably’, ‘probably not’ 
and ‘definitely not’. The practitioner could also state that 
they had not heard of the mentioned bacteria.
The third question was another hypothetical case 
scenario identical to the previous other than that the 
patient was a 10- year- old girl.
Statistical analysis
The 5- grade Likert scale was dichotomised so that ‘strongly 
agree’ and ‘agree’ were merged to ‘agree’ and coded as 
1, while ‘neutral’, ‘disagree’ and ‘strongly disagree’ were 
merged to ‘do not agree’ and coded as 0. Two multivari-
able binary logistic regressions were performed to answer 
two of the primary aims, one with agreeing that throat 
swab is important as the dependent variable, and the 
other that blood tests are important as the dependent 
variable. Practitioner’s age, gender, being senior versus 
being under training and country were independent 
variables.
The third primary aim focused on antibiotic 
prescribing despite no presence of bacteria in the 
throat. The 4- grade Likert scale was dichotomised so 
that ‘yes definitely’ and ‘yes probably’ were merged 
to ‘yes’ and coded as 1, while ‘probably not’ and 
‘definitely not’ were merged to ‘not’ and coded as 
0. Two multivariable binary logistic regressions were 
performed to explore factors associated with anti-
biotic prescribing despite a throat swab showing no 
presence of potentially pathogenic bacteria, one 
regression for each case scenario. Practitioner’s 
age, gender, being senior versus under training and 
country were independent variables.
The findings in the four regression analyses were 
compared with statements in the corresponding 
guidelines (table 1). Adjusted ORs with 95% CIs are 
presented. The level of significance was set to 0.05. 
The statistics software package SPSS Windows V.25 
was used.
Patient and public involvement
The target population for this study are medical practi-
tioners. Medical practitioners were involved in the plan-
ning of this study, and the results will be d’isseminated to 
medical practitioners. Patients and the public were not 
involved.
RESULTS
In total 969 surveys were handed out with 713 (74%) 
returned and 680 (70%) had enough information to be 
analysed (table 2). The 33 returned surveys not included 
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in analysis did not clearly state that the respondent was a 
medical practitioner (table 2).
Primary aims
The multivariable analysis showed that practitioners were 
less likely to agree that throat swabs are of importance in 
Australia (OR 0.40 (95% CI 0.15 to 0.55)), Germany (OR 
0.20 (95% CI 0.11 to 0.35)) and UK (OR 0.15 (95% CI 0.077 
to 0.29)) compared with practitioners from Sweden or the 
USA (table 3). Practitioners from Australia, and especially 
from Germany, perceived blood tests to be of some impor-
tance. UK practitioners were more likely than practitioners 
from other countries to prescribe antibiotics if a throat swab 
showed no growth of any potentially pathogenic bacteria. 
Practitioners from Germany, the USA and especially from 
Sweden would refrain from antibiotics if a throat swab was 
negative while practitioners from the UK would be more 
likely to prescribe antibiotics (table 3).
Secondary aims
The opinion that throat swabs are of importance was 
shared by 88% of participating practitioners in the USA, 
87% in Sweden, 70% in Australia, 61% in Germany and 
54% in the UK (table 4). Practitioners from the UK were 
largely unaware of the existence of FN, while practitioners 
from Australia and the UK were more likely to prescribe 
antibiotics to patients with growth of group C and group 
G Streptococci (table 5).
Other findings were that older practitioners perceived 
blood tests such as leucocyte counts, ESR or CRP as 
important (table 5). However, being a GP or specialist 
consultant made practitioners perceive blood tests or 
throat swabs less important compared with medical prac-
titioners in training.
DISCUSSION
This study found that there were similarities in the 
perceived best antibiotic prescribing strategy for patients 
with an apparently uncomplicated acute sore throat 
between practitioners from countries with very different 
guidelines. However, the study also found a few signifi-
cant differences between countries, largely reflecting 
corresponding differences in guidelines.
Strengths and limitations
This is the first multinational attempt to link specific 
differences in guidelines to medical practitioners’ percep-
tion of best management. The high overall response rate 
is a strength of the study and indicates the generalisability 
of our findings.
Table 2 Response rate and demographic information of participating medical practitioners
Australia Germany Sweden UK USA Total










Surveys handed out, n 156 273 134 110 296 969
Surveys returned, % (n) 96 (150) 66 (181) 79 (106) 83 (91) 63 (185) 74 (713)
Statement of exam/education, n
  Did not state exam/
education
9 8 1 1 3 22
  Statement ambiguous 1 1
  Was not a medical 
practitioner
5 5 10
Surveys included in 
further analysis
141 173 99 90 177 680
Experience as medical practitioner, % (n)
  Senior: GP/consultant 71 (100) 88 (153) 41 (41) 72 (65) 80 (141) 74 (500)
  Under training: 
resident/registrar
29 (41) 12 (20) 59 (58) 18 (25) 20 (36) 26 (180)
Practitioners’ age
  Average age (SD) 42 (11) 52 (10) 41 (10) 40 (9.0) 47 (15) 45 (12)
  Median age (IQR) 41 (32–50) 51 (45–60) 40 (33–48) 39 (32–48) 45 (34–59) 45 (34–55)
Practitioner of female 
gender, % (n)
44 (61) 44 (76) 58 (57) 67 (60) 51 (90) 51 (344)
Year of graduation
  25% percentile 1990 1987 2000 1995 1987 1990
  50% percentile 2000 1994 2009 2004 2002 2000
  75% percentile 2011 2000 2014 2010 2013 2011
 on N
ovem









pen: first published as 10.1136/bm






5Gunnarsson R, et al. BMJ Open 2020;10:e037884. doi:10.1136/bmjopen-2020-037884
Open access
The main limitation is that this study measured percep-
tions and not actual behaviour. Furthermore, being of a 
cross- sectional design, this study cannot clarify if the asso-
ciation between guidelines and medical practitioners’ 
perception should be interpreted so that guidelines directly 
caused the perceptions of the medical practitioners to 
change. Although this is a possible interpretation, given 
that observed differences in perceptions correspond well 
with differences in guidelines, it could not be directly 
proven by this study. It is also possible that guidelines reflect 
usual practice and availability of rapid tests in a country, and 
in effect the guideline is influenced by (rather than influ-
ences) usual practice.
Sweden and Germany have guidelines that can be 
considered as nationwide guidelines for PHC in these 
countries. The situation is somewhat less clear in other 
countries where different guidelines exist. However, we 
believe most Australian GPs would rely on the therapeutic 
guidelines.34 The different US guidelines for manage-
ment of patients with a sore throat are very similar. Most 
UK guidelines would not encourage throat swabbing. We 
have chosen to include the guidelines most likely to be 
used by the practitioners responding to the survey.
The propensity of patients in different countries to visit 
the medical practitioners with a sore throat is likely to be 
an interplay between guidelines, organisation of PHC and 




Dependent variables (one multivariable logistic regression for each column)
Perceived importance of ‘objective’ tests






Adult patient (25 
years)
Child patient (10 
years)
aOR (95% CI), p value aOR (95% CI), p value aOR (95% CI), p value aOR (95% CI), p value
Increasing age (one decade) 1.2 (0.97 to1.5), 
p=0.099
1.3 (1.1 to 1.6), 
p=0.005
0.89 (0.70 to 1.1), 
p=0.35
0.88 (0.70 to 1.1), 
p=0.25
Male gender 0.72 (0.49 to 1.1), 
p=0.093
0.77 (0.53 to 1.1), 
p=0.15
1.2 (0.73 to 1.8), 
p=0.54
1.3 (0.84 to 2.0), 
p=0.24
Senior experience‡ 0.49 (0.29 to 0.86), 
p=0.012
0.52 (0.32 to 0.86), 
p=0.010
1.0 (0.55 to 1.9), 
p=0.98
0.93 (0.52 to 1.6), 
p=0.80
Country
  Australia 0.30 (0.16 to 0.55), 
p<0.001
2.3 (1.4 to 3.8), 
p<0.001
1.6 (0.86 to 3.0), 
p=0.14
1.2 (0.71 to 2.1), 
p=0.46
  Germany 0.20 (0.11 to 0.35), 
p<0.001
7.3 (4.4 to 12), 
p<0.001
0.90 (0.47 to 1.7), 
p=0.74
0.45 (0.24 to 0.83), 
p=0.011
  Sweden 0.73 (0.34 to 1.6), 
p=0.42
0.73 (0.41 to 1.3), 
p=0.28
0.35 (0.13 to 0.96), 
p=0.042
0.19 (0.069 to 0.50), 
p<0.001
  UK 0.15 (0.077 to 0.29), 
p<0.001
1.2 (0.72 to 2.2), 
p=0.44
3.2 (1.7 to 6.1), 
p<0.001
1.7 (0.95 to 3.1), 
p=0.075
  USA (reference) (reference) (reference) (reference) (reference)
Model evaluation and validation
  Included in analysis 640 632 631 621
  Naegelkerke R2 0.16 0.21 0.089 0.10
  Hosmer & Lemeshow§ 11, p=0.23 5.6, p=0.70 4.1, p=0.85 4.8, p=0.78
  Area under curve¶ 0.71 (0.66 to 0.75), 
p<0.001
0.72 (0.69 to 0.76), 
p<0.001
0.68 (0.62 to 0.73), 
p<0.001
0.68 (0.63 to 0.73), 
p=0.025
Statistically significant findings are presented as bold
*Scenario with a patient presenting with a 3- day history of a sore throat and no cough. Physical examination shows red tonsils with a tonsillar 
exudate, tender anterior lymph nodes and temperature of 38.3°C (100.94°F). A throat swab was taken the day before showing no growth of 
any potentially pathogenic bacteria.
†Blood tests with elevated inflammatory markers such as leucocytes, erythrocyte sedimentation rate or CRP.
‡Senior experience such as general practitioner/consultant versus practitioner under training (registrar/resident).
§Χ2, p value.
¶Area under curve (95% CI) and p value obtained at a receiver operating curve analysis.
aOR, adjusted OR; CRP, C reactive protein.
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patient behaviour. This may influence the sorts of sore 
throats that are presented in each country. It was deemed 
very difficult to show exactly how this phenomenon varied 
between countries and possibly influenced the result.
Perception of the value of history, physical examination, 
throat swabs or blood tests may refer either to the impor-
tance of doing/obtaining/ordering these yourself or to the 
importance of the outcome of them. When the practitioner 
perceives that ordering swabs or blood tests is important, it 
would obviously mean to look at the results and consider 
them in management decisions. Hence, for this particular 
scenario these two aspects of perception are likely to overlap 
significantly and represent the same perception.
The perception of the clinical value of throat swabbing 
might be influenced by reimbursement to the doctor for 
using POCT to detect GAS. POCTs to detect GAS are not 
reimbursed in Australia, Sweden or the UK. POCTs are 
reimbursed in the USA and in Germany for patients <16 
years.
The selection of medical practitioners is a convenience 
sample and not a random sample. However, practi-
tioners were not approached based on their interest of 
the topic, only by the fact that they happened to attend 
a formal meeting held for other reasons. In most high- 
income countries, medical practitioners are expected to 
participate in continuous professional education. This 
is formally checked and followed up in some countries, 
while in other countries, it is more of a strong encour-
agement without a formal follow- up. Participation in 
continuous professional education is likely to be higher 
now compared with 20 years ago. Hence, practitioners 
attending an educational meeting is likely a smaller selec-
tion bias today compared with 20 years ago.
The perceived importance of a throat swab
The Swedish and the USA guidelines put a strong 
emphasis on the importance of a throat swab, while the 
Australian and UK guidelines are of the opposite opinion. 
The German guidelines are somewhere in between. 
These differences in guidelines were clearly reflected 
where practitioners from Australia, Germany and the UK 
would be much less inclined to consider a throat swab 
being of any clinical importance (table 3). The lowest 
clinical value of a throat swab (OR of 0.15) was stated by 
medical practitioners from the UK, and their guideline 
was the only one that actively discouraged clinicians from 
using a throat swab.
The guidelines clearly reflect the practitioner’s percep-
tion of the clinical value of a throat swab, but it is hard 
to tell which one is the chicken or the egg, if either. A 
possible alternative explanation is that throat swabs were 
more commonly used, and therefore valued, where 
it was reimbursed by national or private health insur-
ance programmes. Throat swabs were to a larger extent 
perceived as clinically important in Sweden and the USA 
compared with the other countries. However, throat swabs 
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The perceived importance of blood tests
The German guidelines discussed the potential value 
of CRP, while other guidelines mostly disregarded the 
subject of blood tests or briefly stated blood tests were of 
no value. Hence, the finding that German practitioners 
put more emphasis on the clinical value of blood tests 
(OR 7.3) (table 3) is not surprising.
The finding that increasing age of the practitioner is 
associated with relying more on blood tests and that being 
senior (specialists in general practice/family medicine) is 
associated with relying less on blood tests may at first seem 
contradictory. However, it could be explained that older 
practitioners rely more on blood tests because that was more 
common in the past. During registrar/resident training, 
medical practitioners are taught to not rely on blood tests for 
sore throat patients. So, after completing the training and 
becoming a specialist, they should know blood tests add very 
little information in patients with a sore throat. There was 
likely a substantial proportion of practitioners being special-
ists and still also being quite young.
Antibiotic prescribing to patients with no growth of potentially 
pathogenic bacteria
Practitioners in countries with guidelines discouraging the 
use of throat swabs, such as in Australia and the UK, are 
more prone to ignore a throat swab showing no growth of 
any potentially pathogenic bacteria (table 3). Countries 
with a strong emphasis on the clinical importance of throat 
swabs, such as Sweden and the USA, are much less prone to 
prescribe antibiotics if a throat swab shows no pathogens. 
Practitioners from Germany did not perceive a throat swab 
as important, but they had a tendency to respect a negative 
throat swab (table 5). Hence, the guidelines seem to reflect 
the practitioner’s perceptions.
Generalisability
More than one country represented each of the two 
major types of guidelines recommending or discouraging 
the use of throat swabs. The perceived value of taking a 
throat swab was consistent with the corresponding guide-
line in each country. The subsequent perceived impor-
tance of not prescribing antibiotics in case of a negative 
throat swab also followed the corresponding guideline 
although these findings were not statistically significant 
for Australia. The main finding that guidelines seem to 
reflect medical practitioners’ perception is likely to be 
generalisable to high- income countries.
Differences in populations propensity to attend health-
care, culture among practitioners as well as organisation 
of funding for PHC make the consumption of antibiotics 
significantly different between many high- income coun-
tries. The main purpose with this manuscript is to make 
a brief attempt to quantify these differences and identify 
some factors related to them using the sore throat as a 
straight forward example. However, the uncomplicated 
sore throat is just one of many conditions involved. More 
importantly, this publication aim to stress the importance 
of a structured international dialogue to sort out these 
differences that are astonishing given that we all have 
access to the same evidence.
CONCLUSIONS
Guidelines describing the optimal management of 
patients with an apparently uncomplicated acute sore 
throat differ significantly between countries. The guide-
lines studied are based on the same scientific studies 
yet being interpreted very differently. It also seems 
that medical practitioners in different countries have 
different perceptions on how to best manage these 
patients reflecting these differences in guidelines. It 
would be important to try to agree on a best practice for 
patients at low risk for rheumatic fever attending for an 
apparently uncomplicated acute sore throat that can be 
recommended across many high- income countries. This 
international guideline should address the use of throat 
swabs as well as defining etiologic agents where it may be 
relevant to consider antibiotics.
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